No, though her focus on the scourge of HIV (and her optimism) is highlighted. She reiterated that as it currently stands, once on HIV treatment, the treatment is for life.
No way she'd mention anything price sensitive and commercially-focused companies or drugs at the development stage.
Dr Lewin was a consultant for Biotron's BIT225.
No, though her focus on the scourge of HIV (and her optimism) is...
-
- There are more pages in this discussion • 4,238 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |